Analyst Ratings for Hims & Hers Health
Portfolio Pulse from Benzinga Insights
Hims & Hers Health (NYSE:HIMS) has received 3 bullish and 4 indifferent analyst ratings in the last quarter. The average 12-month price target for the stock is $13.0, with a high of $18.00 and a low of $10.00. The average price target has increased by 6.12% over the past month.

June 15, 2023 | 7:01 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Hims & Hers Health has a mix of bullish and indifferent analyst ratings, with an average 12-month price target of $13.0, which has increased by 6.12% over the past month.
The stock has a mix of bullish and indifferent analyst ratings, indicating that there is no clear consensus on the stock's short-term direction. The average 12-month price target has increased by 6.12% over the past month, which may suggest a slightly positive outlook, but the overall sentiment remains mixed. Therefore, the short-term impact on the stock price is neutral.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100